Literature DB >> 20482627

Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice.

Tao Zhang1, Tomoko Kurita-Ochiai, Tomomi Hashizume, Yuan Du, Sumito Oguchi, Masafumi Yamamoto.   

Abstract

Cariogenic and periodontal pathogens are thought to be etiological factors in the development of cardiovascular disease. We assessed the involvement of the periodontal pathogen Aggregatibacter actinomycetemcomitans and cariogenic pathogen Streptococcus mutans in the development of atherosclerosis in apolipoprotein E-deficient spontaneously hyperlipidemic (Apoe(shl)) mice. The mice were treated intravenously with A. actinomycetemcomitans HK1651, S. mutans GS-5, or phosphate-buffered saline three times a week for 3 weeks and killed at 15 weeks of age. The areas of the aortic sinus that were covered with atherosclerotic plaque were significantly larger in Apoe(shl) mice challenged with A. actinomycetemcomitans compared with S. mutans- or vehicle-challenged mice. Aggregatibacter actinomycetemcomitans challenge increased serum high-sensitive C-reactive protein and lipopolysaccharide levels. Bacterial DNA was detected in the blood, heart, and spleen, but not in the liver. Furthermore, serum interleukin-6 (IL-6), IL-8, tumor necrosis factor alpha, and MCP-1 levels and Toll-like receptor (TLR)2, TLR4, ICAM-1, E-selectin, P-selectin, LOX-1, HSP60, CCL19, CCL21, CCR7, and MCP-1 expressions in the aorta were significantly increased in mice challenged with A. actinomycetemcomitans. These results suggest that systemic infection with A. actinomycetemcomitans accelerates atherosclerosis in Apoe(shl) mice by exposing the whole microorganisms or their products, followed by initiating inflammation. Increases in proatherogenic factors may explain the aggravation of atherosclerosis by A. actinomycetemcomitans infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20482627     DOI: 10.1111/j.1574-695X.2010.00674.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  25 in total

Review 1.  Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases.

Authors:  Harvey A Schenkein; Bruno G Loos
Journal:  J Clin Periodontol       Date:  2013-04       Impact factor: 8.728

2.  Increased atherogenesis during Streptococcus mutans infection in ApoE-null mice.

Authors:  L Kesavalu; A R Lucas; R K Verma; L Liu; E Dai; E Sampson; A Progulske-Fox
Journal:  J Dent Res       Date:  2012-01-18       Impact factor: 6.116

3.  Heat-shock protein 60 kDa and atherogenic dyslipidemia in patients with untreated mild periodontitis: a pilot study.

Authors:  Manfredi Rizzo; Francesco Cappello; Rafael Marfil; Luigi Nibali; Antonella Marino Gammazza; Francesca Rappa; Giuseppe Bonaventura; Pablo Galindo-Moreno; Francisco O'Valle; Giovanni Zummo; Everly Conway de Macario; Alberto J L Macario; Francisco Mesa
Journal:  Cell Stress Chaperones       Date:  2012-01-04       Impact factor: 3.667

4.  Lipopolysaccharides mediate leukotoxin secretion in Aggregatibacter actinomycetemcomitans.

Authors:  G Tang; T Kawai; H Komatsuzawa; K P Mintz
Journal:  Mol Oral Microbiol       Date:  2011-12-07       Impact factor: 3.563

5.  Antimicrobial activity against periodontopathogenic bacteria, antioxidant and cytotoxic effects of various extracts from endemic Thermopsis turcica.

Authors:  Elif Burcu Bali; Leyla Açık; Gülçin Akca; Meral Sarper; Mualla Pınar Elçi; Ferit Avcu; Mecit Vural
Journal:  Asian Pac J Trop Biomed       Date:  2014-07

Review 6.  Animal models for periodontal regeneration and peri-implant responses.

Authors:  Alpdogan Kantarci; Hatice Hasturk; Thomas E Van Dyke
Journal:  Periodontol 2000       Date:  2015-06       Impact factor: 7.589

Review 7.  Role of gut microbiota in atherosclerosis.

Authors:  Annika Lindskog Jonsson; Fredrik Bäckhed
Journal:  Nat Rev Cardiol       Date:  2016-12-01       Impact factor: 32.419

8.  In vitro efficacy of diallyl sulfides against the periodontopathogen Aggregatibacter actinomycetemcomitans.

Authors:  Kabilan Velliyagounder; Krishnaraj Ganeshnarayan; Senthil Kumar Velusamy; Daniel H Fine
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

9.  Protective effects of human lactoferrin during Aggregatibacter actinomycetemcomitans-induced bacteremia in lactoferrin-deficient mice.

Authors:  S K Velusamy; R Poojary; R Ardeshna; Waad Alabdulmohsen; D H Fine; K Velliyagounder
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

Review 10.  Sequence meets function-microbiota and cardiovascular disease.

Authors:  Myungsuk Kim; Md Nazmul Huda; Brian J Bennett
Journal:  Cardiovasc Res       Date:  2022-01-29       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.